MedPath

Measurement of the Free Fraction of 25-hydroxyvitamin D in Serum

Completed
Conditions
Impaired Glucose Tolerance
Registration Number
NCT01771380
Lead Sponsor
University of Tromso
Brief Summary

In the circulation 25-hydroxyvitaminD (25(OH)D) is bound to the vitamin D binding protein (DBP) and albumin. According to the free hormone hypothesis, it is, however, the free fraction that is biologically active. Polymorphisms in DBP are related to the serum level of 25(OH)D. As these polymorphisms may also affect the binding affinities for 25(OH)D, the total serum 25(OH)D may not necessary reflect the free fraction. To test this hypothesis, we will calculate the free fraction of 25(OH)D by correction for DBP and albumin content, and also measure free 25(OH)D from equilibrium dialysis and ultra filtration. Furthermore, we will relate total serum 25(OH)D as well as the free and biologically active (free- albumin-bound) 25(OH)D to the well established vitamin D effect marker serum parathyroid hormone as well as to the RNA expression in peripheral blood to evaluate the biological importance of the free versus the total fraction of 25(OH)D. We will invite 300 subjects from an ongoing vitamin D supplementation study to participate in the study which will be one visit only and include collection of blood samples.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Impaired glucose tolerance
  • living in the Tromsø area

Exclusion Criteria

  • pregnancy
  • serious illness
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Free fraction of 25(OH)D1 day
Secondary Outcome Measures
NameTimeMethod
DBP polymorphisms1 day

Trial Locations

Locations (1)

University of Tromsø

🇳🇴

Tromsø, Norway

© Copyright 2025. All Rights Reserved by MedPath